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Twenty one adu lt hor ses, males and females, were pretreated with 0.14 mg/k g of hyosc ine-N-butylbromide intrave nously
and injected 5 minutes late r with 0.0 2 mg/k g, iv of detomidine (group A, n = 9) or saline (gro up B, n = 12). Mea n
arteri al pressure measurement s and electrocardiography were perform ed during 65 minutes. After hyoscine injection
the heart rate was increa sed by 43 % and 65% in A and B groups, respec tively. Heart rate remained increased after
injection of detomidine, returning to baseline values after 15 minutes. No increase in the mean arteri al pressur e
(MAP) was noticed after hyoscine but the MAP was increased by 62% afte r detomidine, returning to basal measurements
until the end of observation time. No additional increase was noted in the group B horses. Hyoscine shortened PR and
QT intervals in both gro ups, but after detomidine, PR and QT interva ls enlarged significan tly at the end of the experi ment.
The second degree atrioventricular block occurred in 3 horses after 40 minutes only in group B. It was concluded that
hyo scine prevented detomidine induced bradycardia and may be an useful dru g combination agai nst the bradycardia
induced by this alph a-2 ago nist, in horses.
UNITE RMS: Scopalamine; Horses; Detomidine.
INTRODUCTION
Detomidine hydrochloride is an alpha-2 agonist drugthat produces profound and long acting sedationby reduction of noradrenaline and dopamine release
in the central nervous system (CNS)8. Both alpha- l and
alpha-2 effects ar e obta ined per iph erally, producin g
vasoconstriction and increased blood pressurev'<" :!".
Bradycardia is often accompanied by atrioventricular heart
block. Approximatel y 60 minutes after detomidine
administration the blood pressure decreases as a result of
bradycardia and persistent effects on alpha-2 receptors in
the CNS 12• Side effects of detomidine administration include
transient reduction in cecal, colonic, and jejunal blood flow.
Anticho linergic age nts may be used to prevent
bradycardia induced by detomidine in horses'. Experiments
with medetomidine in dogs" showed that pretreatment with
atropine was effective against the medetomidine bradycardic
effects. Nevertheless, side effects of anticholinergic use are
tachycardia , high myocardial oxygen consumption, and
intestinal activ ity reduction's".
Hyoscine- N-bu tylbromide is a centra l and
peripherally acting antich ol inergic wide ly used as a
spasmolytic in the treatment of abdominal pain in horses,
that has a shorter pharmacological effect on intestine than
atropine in horses ':", Marques et al." showed that hyoscine
prevent the bradyarrhythmia produced by romifi dine in
horses. The purpose of this study was to determine hyoscine
effects on the cardiovascular changes induced by detomidine
administration in horses.
MATERIAL AND METHOD
Twenty-one adult mixed-breed horses, weighing 37 1
± 56 kg, 14 males and 7 females, were divided in two groups
(A and B). Weight range in group A was 353 ± 4 1 kg (range
300 to 430 kg) and in group B was 390 ± 66 kg (range 295
to 515 kg). The horses were held in separate stalls with
food and water ad libitum. Stainless steel needle electrodes
were placed throu gh the skin at the right fore limb
(negative), left forelimb (positive), and placed just behind
the left elbow over the area of the cardiac apex for recording
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the ECG (VEB ALS 202 - DDR ). Both groups received
hyoscine-N -butylbrom ide (Buscopan, Boehringer De
Angelis, SP, Brazil) 0.14 rng/kg, iv, throu gh a 20 gauge
hyp odermic needle . Five minutes lat er, detomidine
hydrochloride (0.02 mglkg) (Dornosedan, Ciba Geig y, SP,
Braz il) was injected intravenously into nine experimental
animals (group A) or iv saline in equal volume into nine
control animals (group B). In twelve horses (6 animals from
gro up A and 6 from gro up B), a sterile polypropylene
catheter - 190 (Medical's Produ cts- SP, Brazil) was inserted
aseptically into a facial artery on the ventral surface of the
mandible. The catheter was connected to a transducer placed
at the cardiac base level for measurement and recording of
sy sto lic (SAP) and di astoli c (DAP) arte ria l pressure
(Physiograph- DMP-4B Narco Bio-Systems, TA- USA). The
mean arterial pressure (MAP) was obtained by calculation
DAP + (SAP - DAP)/3 . Heart rate (HR), PR and QT
intervals were obtained from measurements of the ECG.
Lowering of the head and onset of calm behaviour of the
horses after drug administration were considered to be
clin ical signs of sedation. The experiments were conducted
in the aftern oon .
The horses were maintained in a restraint stock for
30 minutes and then the baseline value s for SAP, DAP,
MAP, ECG (HR, PR and QT) and behaviour were obtained
before injection of hyoscine. Values were recorded 5 minutes
later, before injection of detomidine (group A) or saline
(group B). Value s were recorded again 2 minutes after
detomidine or saline inje ction. Further recordings were
made between 10 and 25 minut es at 5 minutes intervals,
and then at 10 minutes intervals for a total of 65 minutes.
Statistical analysis
Results are presented as mean ± standard deviation .
On e-way ana lys is of var iance (ANOVA) wa s used to
evaluate the data, followed by Student-Newman-Keuls test.
Difference was considered significant when p ::;; 0.05. To
comp are the results of the two groups was used the Student
paired t-test (p ::;; 0.05).
RESULTS
All results are summarized in the Tab. I. Baseline
heart rate (HR) was 44 ± 8 and 40 ± 5 beats/min. and mean
arterial pressure (MAP) was 147 ± 24 (n = 6) and 125 ± 10
(n = 6) mmHg in group A and B, respectively. The hyoscine
injection increased the HR to 63 ± II beats/min (group A)
and 69 ± 15 beats/min (group B) at the 5 minutes and no
changes was noted in the MAP (Fig. I ). The heart rate
increase was noticed and at the ECG trace was observed
shortening of the QT interval from 488 ± 40 to 449 ± 44
milliseconds and 538 ± 29 to 440 ± 45 in the group A and B
horses, respectively (Fig. I ). The PR intervals were reduced
but no significant changes were observed in both groups,
after HBB.
Administration of detomidine result ed in typ ical
behaviour changes in the experimental horses , with sedation
and dropped heads. Initially the HR remained ele vated,
decreasing to baseline values after 15 minutes, and QT
significantly lengthened from 45 minutes until the end of
the observation time. The PR intervals in the group A were
stable and the reduction in the group B was not significant.
No ar rh ythmias were noted until 45 minutes, when
atrioventricular heart block was recorded in 3 horses. The
AV block occurred regularly at every third to fifth beats .
Before admini stration of detomidine, MAP was 172 ± 24
Table 1
Cardiovascul ar change s in horses given hyoscine-N-but yl bromide (HBB) (0.14 mglkg iv) and following five minutes, detomidine
(DET) (0.02 mglkg iv) or saline (SAL). Jaboticabal, nov. 1995.
Time Heart rate ± sd PR interval ± sd QT interval ± sd MAP ± sd
(min) (beats/min.) (milliseconds) (milliseconds) (mm Hg)
HBB DET HBB SAL HBB DET HBB SAL HBB DET HBB SAL HBB DET HSS SAL
0 44 ± 8 40 ± 5 300 ± 37 280 ± 35 489 ± 48 533 ± 28 147 ± 24 125 ± 11
5 63 ± 11- 69 ± 15- 278 ± 21 260 ± 32 449 ± 44 440 ± 45- 172 ± 24 158 ± 20
7 58 ± 12* 70 ± 17* 300 ± 25· 258 ± 44 462 ± 53 413 ± 80- 237 ± 15-· 156 ± 19
10 57 ± 10- 71 ± 18- 300 ± 25# 251 ± 30 480 ± 53 427 ± 85- 229 ± 20- · 147 ± 22
15 57 ± g- 62 ± 8* 313 ± 40 276 ± 37 502 ± 49 453 ± 57 225 ± 23* · 143 ± 18
20 53 ± 7 57 ± 11- 320 ± 40 291 ± 46 511 ± 44 476 ± 55 215 ± 21*# 138 ± 20
25 49 ± 6 51 ± 8 329 ± 39 287 ± 45 529 ± 44 484 ± 62 204 ± 16- · 137 ± 18
35 43 ± 6 47 ± 7 333 ± 40 11 284 ±42 556 ± 51' · 493 ± 60 184 ± 19* · 132 ± 20
45 38 ± 7 42 ± 4 336 ± 34· 287 ± 40 578 ± 45* /1 524 ± 37 164 ± 17# 129 ± 17
55 36 ± 8 43 ± 6 336 ± 28· 287 ± 40 578 ± 57" 529 ± 39 151± 181' 128 ± 15
65 36 ± 8 42 ± 8 338±41 11 282 ±43 578 ± 57" 529 ± 44 138 ± 26 127 ± 15
* -significantly different from time 0 values (p $ 0.05 Student-Newman-Keuls test);
# - significantly different from group HBB-SAL (p $ 0.05 Student t-test).
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was higher in group A, from 7 to 35 minutes. Baseline QT
interval was higher in salline group and decreases after
hyoscine injection. In the detomidine treated gro up QT was
increased from 35 until 65 minutes compared to gro up B.
At the group A and B the PR was not different from time
zero , and differences between groups at time 7; 10 and 35
to 65 minutes (Fig. I) were noticed.
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Figure 1
Heart rate and mean arterial pressure increased after injection of
hyoscine (HBB), 0.14 mg/kg. Detomidine (DET), 0.02 mg/kg iv,
resulted in no change or a decrease in HR and a significant increase
in MAP. PR and QT decreased after injection of HBB, DET, caused
a significant increase in QT. Data are mean ± SEM . • Significantly
different from time 0 (p :s; 0.05 Student-New man-Keuls test).
' Significantly different from group B (p :s; 0.05 Student t-test).
mmHg. A significant increase in MAP (62 %) was measured
at 7 minutes. MAP rem ained incre ased until 35 minutes,
and progressively decreased to baseline values until the end
of the experi men t (Fig. I).
Th e contro l horses were ca lm throu ghout the study.
Th e HR was increased until 20 min after hyoscine. Salin e
injectio n resulted in no further increase in HR and MAP.
No arr hythmias were noticed in the con tro l horses.
Comparison between treatments showed that MAP
DISCUSSION
Premedication with an anticho linergic drug is more
effective in preventing bradycardia associated with an alpha-
2 agonist than treatment of established bradycardia " . Th e
detomidine induced bradycard ia and atrioventricular block
had been corre lated with a decrease in the cardiac output".
In our study, the hyoscine injection increased the HR and
prevented the brady cardia and atrioventricular heart block
during the initial period in horses given detomidine, probably
through reduction in vaga l activity.
In thi s study, hyosc ine increased heart ra te in
experimental and control horses. The brief period of
tachycardi a observed in detomidine treated gro up may be
attributed to the alpha-2 agonist medi ated increase in vagal
ton e!", which co unteracts th e anticholinergic-induced
tachycardia.
It has been slated that prolongation and reduction of
PR and QT interval may be associated with changes in heart
rate" . Indeed in our study hyoscine induced tachycardia
resulted in QT shortening during 15 minutes in contro l group .
Ad di tiona lly, in de tomidi ne treated group, cardiac rate
reduction was coincident with significant prolongation of QT
interval after 45 minutes. The observation of second-degree
atrioventricular blocks in three horses was also coincident with
QT enlargement but'no changes were observed at the same
period for the PR intervals. These data sugges t that reduction
of hyoscine ac tio n and the la te pr eval en ce of central
sympatholytic effect of detornidine'v"? may be responsible
for the atrioventricular heart block and increased QT interval.
The cardiac effects of detomidine use in horses had
been subject ofconsiderable discussion. Atropine injection was
recommended to prevent detomidine induced bradycardia".
The effect ofhyoscine for this purpose has not been previously
reported. It is well known that the immediate effect of the
intravenous injec tion of this alpha-2 agonist is vasoconstriction
and increased blood pressure by stimulation of post-synaptic
adenoreceptors". The mean arterial pressure recorded after
hyoscine/detomidine administration was substantially higher
than values reported for detomid ine alone' :". It may be that
hyoscine induced vagal blockade potentiated detomidine
hypertensive action" :". In a preliminary report, Young et al.20
observed that atropine sulphate also prevented the heart rate
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drop caused by the alpha-2 agonist romifidine and resulted in
marked hypertension. Similarly, Marques et at.10 described
that hyoscine antagonized the romifidine bradyarrhytmias.
A libhai et al .? also observed prolonged and intense
hypertension when anticholinergic is associated with alpha-2
agonists in dogs . The tachycardia and hypertension observed
when hyoscine is used before detomidine may be deleterious
by increa sing myoc ardial oxygen demand. Although not
investigated in this study, further studies may be indicated to
investigate if these effects may be attenuated by intramuscular
injection or the use of lower dosage s of hyoscine .
Th e effect of anticholinergic drugs on intestinal
mo til ity is of concern in hor ses. Hyoscine has a shorter
durati on of action than atropine and reduces peristalsis with
no alteration in the electrical pattem'v". Indeed, the use of
atropine in horses had been correlated with prolonged gut
stasis and colic", Although there are no studies comparing
the cardiovascular effects of hyoscine and atropine, its use
for preventing bradycardia may be preferred to prevent or
treat bradycardia in horses because of its shorter action and
lower reduction in gastrointestinal motility.
In summary, pretreatment with hyoscine was
effective against the arrhythmogenic activity of detomidine,
and produced an additional increase in blood pressure.
Therefore, its routine use before detomidine must be
considered in regard to its hypertensive response.
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RESUMO
Avaliaram-se os efeitos cardiovasculares do N-butilbrometo de hioscina (BBH) associado 11 detomidina (DET) em eqiiinos.
Empregaram-se 21 eqiiinos adultos pre-medicados, por via intravenosa (iv), com 0,14 mg/kg de BBH. Decorridos 5
minutos, os animais do grupo A receberam DET na dose de 0,02 mg/kg/iv e aqueles do grupo B receberam salina.
Avaliou-se a pressao arterial media (PAM), atividade cardfaca, por eletrocardiografia (ECG) antes da administracao do
BBH e, depois , a intervalos de 5 minutos , ate os 25 minuto s. Ap6s este perfodo, colheram-se os dados a cada 10 minutos
ate os 65 minutos. A administracao do BBH aumentou a frequencia cardfaca (FC) em 43% e 65%, respectivamente, nos
grupo s A e B. A FC permaneceu aumentada ate 15 minutos da administracao da DET. A PAM nao aumentou ap6s a
administracao do BBH, porem foi registrado urn aumento de 62% ap6s a aplicacao da DET, retomando aos niveis basais
ao final do experimento. A aplicacao de DET no grupo B nao elevou a PAM. A administracao do BBH reduziu os
interva los PR e QT em ambos os grupos. Ap6 s a aplicacao de DET, os interv alos PR e QT aumentaram e foram
significativamente maiores ao final do experimento. 0 bloqueio atrioventricular de 2.° grau (BAV-2.0) ocorreu em 3
animais do grupo B, porem , sempre ap6s 40 minuto s da administracao da DET. Concluiu- se que 0 BBH bloqueou a
atividade arritmogenica da detomidina e produziu aumento na pressao arterial , a ser considerado quando do emprego
dessa associacao rotineiramente.
UNITERMOS: Escopolamina; Eqiiino s; Detomidina.
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